YCM
LSTA icon

Yakira Capital Management’s Lisata Therapeutics LSTA Stock Holding History

Yakira Capital Management’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$471K Buy
+138,561
New +$493K 0.13% 125

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.14% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities New York $4.75B AUM 41.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Yakira Capital Management's LSTA Position: Q2 2026 in Review

Yakira Capital Management opened a new position in Lisata Therapeutics (LSTA) in Q2 2026: 138,561 shares worth $471K. The stake represents 0.13% of the portfolio and ranks #125 among its holdings.

30 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • Yakira Capital Management held 138,561 shares of Lisata Therapeutics worth $471K as of Q2 2026.
  • Lisata Therapeutics was a new Yakira Capital Management position in Q2 2026.
  • Lisata Therapeutics made up 0.13% of Yakira Capital Management's portfolio in Q2 2026, its #125 holding.
  • 30 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on Yakira Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.